A Study of GQ1010 in Subjects With Advanced Solid Tumors

NCT06464055 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: Dose Escalation
DRUG: Dose Expansion1
DRUG: Dose Expansion2
DRUG: Dose Expansion3
DRUG: phase II

Sponsor

GeneQuantum Healthcare (Suzhou) Co., Ltd.